Pevonedistat-1014: A Randomized, Crossover Phase I Study to Evaluate the Effects of Pevonedistat on the QTc Interval in Patients with Advanced Solid Tumors

March 20, 2018
Cancer - Head and Neck, Cancer - Lung, Cancer - Breast, Cancer - Ovarian, Cancer - Lymphoma, Cancer - Melanoma, Solid Tumors
Principal Investigator: Ding Wang, MD
breast cancer, ovarian cancer, advanced cancer, melanoma, NSCLC, lung cancer, lymphoma, head and neck cancer
Accepting Participants